LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 18

Search options

  1. Article ; Online: Emergence of meropenem and levofloxacin resistance in Burkholderia pseudomallei in Taiwan.

    Wu, Pin-Han / Chen, Chih-Hao / Hsih, Wen-Hsin / Chou, Chia-Huei / Chi, Chih-Yu / Ho, Mao-Wang / Lin, Yu-Tzu / Lin, Hsiu-Hsien / Tseng, Kun-Hao / Hsueh, Po-Ren

    The Journal of infection

    2023  Volume 86, Issue 6, Page(s) e161–e163

    MeSH term(s) Humans ; Meropenem/pharmacology ; Burkholderia pseudomallei/genetics ; Levofloxacin/pharmacology ; Levofloxacin/therapeutic use ; Taiwan/epidemiology ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Melioidosis/drug therapy ; Melioidosis/epidemiology
    Chemical Substances Meropenem (FV9J3JU8B1) ; Levofloxacin (6GNT3Y5LMF) ; Anti-Bacterial Agents
    Language English
    Publishing date 2023-03-30
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 424417-5
    ISSN 1532-2742 ; 0163-4453
    ISSN (online) 1532-2742
    ISSN 0163-4453
    DOI 10.1016/j.jinf.2023.03.022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Cryptococcus tetragattii Meningitis Associated with Travel, Taiwan.

    Wu, Pin-Han / Chen, Chih-Hao / Lin, Yu-Tzu / Ao, Yu / Lin, Kuo-Hsi / Hsih, Wen-Hsin / Chou, Chia-Huei / Chi, Chih-Yu / Ho, Mao-Wang / Hsueh, Po-Ren

    Emerging infectious diseases

    2023  Volume 29, Issue 2, Page(s) 447–448

    Abstract: Meningitis caused by Cryptococcus tetragattii fungus is rare and has been found in specific geographic regions. We report a case of meningitis caused by C. tetragattii (molecular type VGIV) in an immunocompetent patient in Taiwan. The patient had ... ...

    Abstract Meningitis caused by Cryptococcus tetragattii fungus is rare and has been found in specific geographic regions. We report a case of meningitis caused by C. tetragattii (molecular type VGIV) in an immunocompetent patient in Taiwan. The patient had traveled to Egypt and was positive for granulocyte-macrophage colony-stimulating factor autoantibody.
    MeSH term(s) Humans ; Taiwan ; Meningitis, Cryptococcal/diagnosis ; Meningitis, Cryptococcal/drug therapy ; Cryptococcus ; Meningitis ; Fungi
    Language English
    Publishing date 2023-01-24
    Publishing country United States
    Document type Case Reports ; Letter
    ZDB-ID 1380686-5
    ISSN 1080-6059 ; 1080-6040
    ISSN (online) 1080-6059
    ISSN 1080-6040
    DOI 10.3201/eid2902.221425
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Genomic characteristics of SARS-CoV-2 variants and their clinical impact on patients with COVID-19 in Taiwan.

    Su, Hung-Chieh / Lai, Zi-Lun / Chang, Yu-Chang / Cheng, Meng-Yu / Hsih, Wen-Hsin / Chen, Yi-Jhen / Chou, Chia-Huei / Chen, Chieh-Lung / Lin, Yu-Chao / Lin, Tsai-Hsiu / Hsiao, Chiung-Tzu / Ho, Mao-Wang / Shih, Hong-Mo / Hsueh, Po-Ren / Cho, Der-Yang

    The Journal of infection

    2023  Volume 87, Issue 3, Page(s) 263–266

    MeSH term(s) Humans ; SARS-CoV-2/genetics ; COVID-19 ; Taiwan/epidemiology ; Genomics
    Language English
    Publishing date 2023-06-27
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 424417-5
    ISSN 1532-2742 ; 0163-4453
    ISSN (online) 1532-2742
    ISSN 0163-4453
    DOI 10.1016/j.jinf.2023.06.017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment.

    Wu, Huan-Yi / Chang, Peng-Hao / Chen, Kuan-Yu / Lin, I-Fan / Hsih, Wen-Hsin / Tsai, Wan-Lin / Chen, Jiun-An / Lee, Susan Shin-Jung

    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

    2022  

    Abstract: Coronavirus disease 2019 (COVID-19) emerged as a pandemic that spread rapidly around the world, causing nearly 500 billion infections and more than 6 million deaths to date. During the first wave of the pandemic, empirical antibiotics was prescribed in ... ...

    Abstract Coronavirus disease 2019 (COVID-19) emerged as a pandemic that spread rapidly around the world, causing nearly 500 billion infections and more than 6 million deaths to date. During the first wave of the pandemic, empirical antibiotics was prescribed in over 70% of hospitalized COVID-19 patients. However, research now shows a low incidence rate of bacterial coinfection in hospitalized COVID-19 patients, between 2.5% and 5.1%. The rate of secondary infections was 3.7% in overall, but can be as high as 41.9% in the intensive care units. Over-prescription of antibiotics to treat COVID-19 patients fueled the ongoing antimicrobial resistance globally. Diagnosis of bacterial coinfection is challenging due to indistinguishable clinical presentations with overlapping lower respiratory tract symptoms such as fever, cough and dyspnea. Other diagnostic methods include conventional culture, diagnostic syndromic testing, serology test and biomarkers. COVID-19 patients with bacterial coinfection or secondary infection have a higher in-hospital mortality and longer length of stay, timely and appropriate antibiotic use aided by accurate diagnosis is crucial to improve patient outcome and prevent antimicrobial resistance.
    Language English
    Publishing date 2022-10-07
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1497590-7
    ISSN 1995-9133 ; 1684-1182 ; 0253-2662
    ISSN (online) 1995-9133
    ISSN 1684-1182 ; 0253-2662
    DOI 10.1016/j.jmii.2022.09.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Definite therapy of mixed infection alleviates refractory dilemma of adult chronic suppurative otitis media.

    Chen, Chih-Hao / Wang, Ching-Yuan / Cheng, Meng-Yu / Hsih, Wen-Hsin / Tien, Ni / Chou, Chia-Huei / Lin, Po-Chang / Chi, Chih-Yu / Ho, Mao-Wang / Lu, Min-Chi

    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

    2022  

    Abstract: The characteristics, risk factors, microbial distributions and effective treatment regimens for Chronic suppurative otitis media (CSOM) patients intractable to empirical therapy were analyzed. Adult CSOM patients of China Medical University Hospital from ...

    Abstract The characteristics, risk factors, microbial distributions and effective treatment regimens for Chronic suppurative otitis media (CSOM) patients intractable to empirical therapy were analyzed. Adult CSOM patients of China Medical University Hospital from 2018 to 2020 were included. Subjects of refractory and non-refractory groups were investigated for characteristics of age, sex, nation, comorbidities, otomycosis, and associated complications. Risk factors, microbiology distributions, and treatment regimens were analyzed. Twenty-six refractory patients (55.0 ± 17.7 years) and 66 non-refractory patients (54.1 ± 13.7 years) were studied. A significantly higher rate of otomycosis and CSOM complications was observed in refractory group than in non-refractory one (73.1% vs. 36.4%; p = 0.002; 57.7% vs. 10.6%, p < 0.001, respectively). Multivariate analysis revealed atopic diathesis (p = 0.048), otomycosis (p = 0.003) and CSOM complications (p < 0.001) were risk factors of refractory CSOM. Coagulase-negative staphylococci (CoNS) and methicillin-resistant Staphylococcus aureus (MRSA) were the prevailing pathogens. Patients of refractory group tented to have higher rates of mixed infection (42.9%% vs. 23.7%) and significantly more included fungal pathogen (19.0% vs. 2.6%; p = 0.049) than those of non-refractory cohort. Topical treatment of fungus significantly improved outcome of refractory CSOM. Atopic diathesis, otomycosis, and CSOM-associated complications were risk factors of refractory CSOM. Systemic and local treatment to possible drug-resistant pathogens, likely CoNS and fungus, possible improves recalcitrant CSOM. Correspondingly, early identification of CSOM complications, routine culture and susceptibility testing and treatment of resistant bacteria and fungus are key elements to the successful management of adult CSOM.
    Language English
    Publishing date 2022-08-21
    Publishing country England
    Document type Journal Article
    ZDB-ID 1497590-7
    ISSN 1995-9133 ; 1684-1182 ; 0253-2662
    ISSN (online) 1995-9133
    ISSN 1684-1182 ; 0253-2662
    DOI 10.1016/j.jmii.2022.07.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Featuring COVID-19 cases via screening symptomatic patients with epidemiologic link during flu season in a medical center of central Taiwan.

    Hsih, Wen-Hsin / Cheng, Meng-Yu / Ho, Mao-Wang / Chou, Chia-Huei / Lin, Po-Chang / Chi, Chih-Yu / Liao, Wei-Chih / Chen, Chih-Yu / Leong, Lih-Ying / Tien, Ni / Lai, Huan-Cheng / Lai, Yi-Chyi / Lu, Min-Chi

    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

    2020  Volume 53, Issue 3, Page(s) 459–466

    Abstract: Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CO-V-2), was first reported in Wuhan, Hubei province, China has now rapidly spread over 50 countries. For the prevention and control of ... ...

    Abstract Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CO-V-2), was first reported in Wuhan, Hubei province, China has now rapidly spread over 50 countries. For the prevention and control of infection, Taiwan Centers for Disease Control initiated testing of SARS-CoV-2 on January 24th 2020 for persons suspected with this disease. Until February 28th, 43 flu-like symptomatic patients were screened in China Medical University Hospital.
    Methods: Two patients were confirmed positive for SARS-CoV-2 infection by rRT-PCR as COVID-19 patients A and B. Causative pathogens for included patients were detected using FilmArray™ Respiratory Panel. We retrospectively analyzed the clinical presentations, laboratory data, radiologic findings, and travel and exposure contact histories, of the COVID-19 patients in comparison to those with other respiratory infections.
    Results: Through contact with Taiwan No. 19 case patient on 27th January, COVID-19 patients A and B were infected. Both patients had no identified comorbidities and developed mild illness with temporal fever, persistent cough, and lung interstitial infiltrates. Owing to the persistence of positive SARS-CoV-2 in respiratory specimen, the two COVID-19 patients are still in the isolation rooms despite recovery until 10th of March. The results of FilmArrayTM Respiratory Panel revealed 22 of the 41 non-COVID-19 patients were infected by particular pathogens. In general, seasonal respiratory pathogens are more prevalent than SARS-CoV-2 in symptomatic patients in non- COVID-19 endemic area during the flu season. Since all patients shared similar clinical and laboratory findings, expanded surveillance of detailed exposure history for suspected patients and application of rapid detection tools are highly recommended.
    MeSH term(s) Betacoronavirus/isolation & purification ; COVID-19 ; Coronavirus Infections/diagnosis ; Coronavirus Infections/epidemiology ; Humans ; Mass Screening/methods ; Pandemics ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/epidemiology ; Retrospective Studies ; SARS-CoV-2 ; Seasons ; Taiwan/epidemiology ; Travel
    Keywords covid19
    Language English
    Publishing date 2020-03-13
    Publishing country England
    Document type Journal Article
    ZDB-ID 1497590-7
    ISSN 1995-9133 ; 1684-1182 ; 0253-2662
    ISSN (online) 1995-9133
    ISSN 1684-1182 ; 0253-2662
    DOI 10.1016/j.jmii.2020.03.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Younger adults with mild-to-moderate COVID-19 exhibited more prevalent olfactory dysfunction in Taiwan.

    Cheng, Meng-Yu / Hsih, Wen-Hsin / Ho, Mao-Wang / Lai, Yi-Chyi / Liao, Wei-Chih / Chen, Chih-Yu / Chen, Tsung-Chia / Lee, Yu-Lin / Liu, Po-Yu / Kao, Chih-Chuan / Chou, Chia-Huei / Lin, Po-Chang / Chi, Chih-Yu / Leong, Lih-Ying / Tai, Chih-Jaan / Lu, Min-Chi

    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

    2021  Volume 54, Issue 5, Page(s) 794–800

    Abstract: Background: Coronavirus Disease 2019 (COVID-19) is rapidly transmitted from person to person, causing global pandemic since December 2019. Instantly detecting COVID-19 is crucial for epidemic prevention. In this study, olfactory dysfunction is a ... ...

    Abstract Background: Coronavirus Disease 2019 (COVID-19) is rapidly transmitted from person to person, causing global pandemic since December 2019. Instantly detecting COVID-19 is crucial for epidemic prevention. In this study, olfactory dysfunction is a significant symptom in mild to moderate COVID-19 patients but relatively rare in other respiratory viral infections. The Taiwan smell identification test (TWSIT) is a speedy and inexpensive option for accurately distinguishing anosmia that also quantifies the degree of anosmia. Using TWSIT in the outpatient clinic for early identifying the patients with mild to moderate COVID-19 can be promising.
    Methods: Nineteen patients confirmed COVID-19 in central Taiwan were collected and divided into two groups: olfactory dysfunction and non-olfactory dysfunction. Demographic characteristics, laboratory findings, and the results of the olfactory test were compared between these two groups.
    Findings: Thirteen (68.4%) of the 19 patients had olfactory dysfunction. The patients with olfactory dysfunction were younger than those without this symptom. The statistical difference in age distribution was significant between these two groups (IQR: 25.5-35.5 vs. IQR: 32.5-60.3; p-value: 0.012). There was no significant difference in gender, smoking history, comorbidities, travel history, respiratory tract infection symptoms, and laboratory findings between these two groups.
    Conclusion: This study demonstrated that young adults were prone to develop olfactory dysfunctions. In the flu season, olfactory dysfunction is considered a specific screening criterion for early detecting COVID-19 in the community. TWSIT can serve as a decent test for quantifying and qualifying olfactory dysfunction.
    MeSH term(s) Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anosmia ; COVID-19/complications ; COVID-19/epidemiology ; COVID-19/etiology ; Child ; Early Diagnosis ; Female ; Humans ; Male ; Middle Aged ; Olfaction Disorders/diagnosis ; Olfaction Disorders/epidemiology ; Olfaction Disorders/etiology ; Pandemics ; SARS-CoV-2 ; Taiwan/epidemiology ; Young Adult
    Language English
    Publishing date 2021-02-08
    Publishing country England
    Document type Journal Article
    ZDB-ID 1497590-7
    ISSN 1995-9133 ; 1684-1182 ; 0253-2662
    ISSN (online) 1995-9133
    ISSN 1684-1182 ; 0253-2662
    DOI 10.1016/j.jmii.2021.01.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Featuring COVID-19 cases via screening symptomatic patients with epidemiologic link during flu season in a medical center of central Taiwan

    Wen-Hsin Hsih / Meng-Yu Cheng / Mao-Wang Ho / Chia-Huei Chou / Po-Chang Lin / Chih-Yu Chi / Wei-Chih Liao / Chih-Yu Chen / Lih-Ying Leong / Ni Tien / Huan-Cheng Lai / Yi-Chyi Lai / Min-Chi Lu

    Journal of Microbiology, Immunology and Infection, Vol 53, Iss 3, Pp 459-

    2020  Volume 466

    Abstract: Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CO-V-2), was first reported in Wuhan, Hubei province, China has now rapidly spread over 50 countries. For the prevention and control of ... ...

    Abstract Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CO-V-2), was first reported in Wuhan, Hubei province, China has now rapidly spread over 50 countries. For the prevention and control of infection, Taiwan Centers for Disease Control initiated testing of SARS-CoV-2 on January 24th 2020 for persons suspected with this disease. Until February 28th, 43 flu-like symptomatic patients were screened in China Medical University Hospital. Methods: Two patients were confirmed positive for SARS-CoV-2 infection by rRT-PCR as COVID-19 patients A and B. Causative pathogens for included patients were detected using FilmArray™ Respiratory Panel. We retrospectively analyzed the clinical presentations, laboratory data, radiologic findings, and travel and exposure contact histories, of the COVID-19 patients in comparison to those with other respiratory infections. Results: Through contact with Taiwan No. 19 case patient on 27th January, COVID-19 patients A and B were infected. Both patients had no identified comorbidities and developed mild illness with temporal fever, persistent cough, and lung interstitial infiltrates. Owing to the persistence of positive SARS-CoV-2 in respiratory specimen, the two COVID-19 patients are still in the isolation rooms despite recovery until 10th of March. The results of FilmArrayTM Respiratory Panel revealed 22 of the 41 non-COVID-19 patients were infected by particular pathogens. In general, seasonal respiratory pathogens are more prevalent than SARS-CoV-2 in symptomatic patients in non- COVID-19 endemic area during the flu season. Since all patients shared similar clinical and laboratory findings, expanded surveillance of detailed exposure history for suspected patients and application of rapid detection tools are highly recommended.
    Keywords COVID-19 ; SARS-CO-V-2 ; FilmArray™ Respiratory Panel ; Microbiology ; QR1-502 ; covid19
    Subject code 610
    Language English
    Publishing date 2020-06-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Featuring COVID-19 cases via screening symptomatic patients with epidemiologic link during flu season in a medical center of central Taiwan

    Hsih, Wen-Hsin / Cheng, Meng-Yu / Ho, Mao-Wang / Chou, Chia-Huei / Lin, Po-Chang / Chi, Chih-Yu / Liao, Wei-Chih / Chen, Chih-Yu / Leong, Lih-Ying / Tien, Ni / Lai, Huan-Cheng / Lai, Yi-Chyi / Lu, Min-Chi

    Journal of Microbiology, Immunology and Infection

    2020  Volume 53, Issue 3, Page(s) 459–466

    Keywords Immunology and Allergy ; Microbiology (medical) ; General Immunology and Microbiology ; Infectious Diseases ; General Medicine ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 1497590-7
    ISSN 1684-1182 ; 0253-2662
    ISSN 1684-1182 ; 0253-2662
    DOI 10.1016/j.jmii.2020.03.008
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan.

    Wu, Huan-Yi / Chang, Peng-Hao / Huang, Yu-Shan / Tsai, Chin-Shiang / Chen, Kuan-Yu / Lin, I-Fan / Hsih, Wen-Hsin / Tsai, Wan-Lin / Chen, Jiun-An / Yang, Te-Liang / Lee, Chun-Yuan / Ho, Tzong-Shiann / Wang, Hsiao-Wei / Huang, Shiang-Fen / Wu, Alice Ying-Jung / Chen, Hung-Jui / Chen, Yi-Ching / Chen, Wan-Chen / Tseng, Chien-Hao /
    Lin, Pei-Chin / Yang, Ching-Hsiang / Hong, Pi-Lien / Lee, Susan Shin-Jung / Chen, Yao-Shen / Liu, Yung-Ching / Wang, Fu-Der

    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

    2022  Volume 56, Issue 2, Page(s) 207–235

    Abstract: Coronavirus disease-19 (COVID-19) is an emerging infectious disease caused by SARS-CoV-2 that has rapidly evolved into a pandemic to cause over 600 million infections and more than 6.6 million deaths up to Nov 25, 2022. COVID-19 carries a high mortality ... ...

    Abstract Coronavirus disease-19 (COVID-19) is an emerging infectious disease caused by SARS-CoV-2 that has rapidly evolved into a pandemic to cause over 600 million infections and more than 6.6 million deaths up to Nov 25, 2022. COVID-19 carries a high mortality rate in severe cases. Co-infections and secondary infections with other micro-organisms, such as bacterial and fungus, further increases the mortality and complicates the diagnosis and management of COVID-19. The current guideline provides guidance to physicians for the management and treatment of patients with COVID-19 associated bacterial and fungal infections, including COVID-19 associated bacterial infections (CABI), pulmonary aspergillosis (CAPA), candidiasis (CAC) and mucormycosis (CAM). Recommendations were drafted by the 7th Guidelines Recommendations for Evidence-based Antimicrobial agents use Taiwan (GREAT) working group after review of the current evidence, using the grading of recommendations assessment, development, and evaluation (GRADE) methodology. A nationwide expert panel reviewed the recommendations in March 2022, and the guideline was endorsed by the Infectious Diseases Society of Taiwan (IDST). This guideline includes the epidemiology, diagnostic methods and treatment recommendations for COVID-19 associated infections. The aim of this guideline is to provide guidance to physicians who are involved in the medical care for patients with COVID-19 during the ongoing COVID-19 pandemic.
    MeSH term(s) Humans ; COVID-19/diagnosis ; COVID-19/epidemiology ; SARS-CoV-2 ; Taiwan/epidemiology ; Pandemics ; Mycoses/diagnosis ; Mycoses/drug therapy ; COVID-19 Testing
    Language English
    Publishing date 2022-12-21
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1497590-7
    ISSN 1995-9133 ; 1684-1182 ; 0253-2662
    ISSN (online) 1995-9133
    ISSN 1684-1182 ; 0253-2662
    DOI 10.1016/j.jmii.2022.12.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top